According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are HK$13.84 Billion. In 2023 the company made an earning of HK$32.62 Billion a decrease over its 2022 earnings that were of HK$37.75 Billion. The earnings displayed on this page is the company's Pretax Income.